01—Abstract
Summary
Summary of the 8-K filed February 18, 2025. Cited figures are marked; the original filing is the authoritative source.
HCA Healthcare's wholly owned subsidiary, HCA Inc. (the Issuer), announced a proposed public offering of senior unsecured notes on February 18, 2025.
The filing describes a refinancing package rather than a new growth initiative. As of February 14, 2025, the Issuer had borrowed $2.950 billiona under its ABL credit facility, part of which was used to repay at maturity the full $2.600 billion of 5.375% Senior Notes due 2025. The Issuer intends to terminate its existing secured Cash Flow and ABL credit facilities, which mature June 30, 2026 absent termination, and replace them with an $8.000 billion, five-year senior unsecured revolving credit facility.
The Cash Flow facility carried $1.238 billionb of term loan A outstanding at December 31, 2024. For investors, the key changes are a shift from secured to unsecured debt and a move away from guarantees. The new facility will not be guaranteed by HCA Healthcare or any subsidiary of the Issuer, and it will carry a quarterly maximum leverage covenant of 4.50x, which can step up to 5.00x for certain periods after a material acquisition.
Initial pricing is expected at Term SOFR plus 1.25%c plus a 0.10% credit spread adjustment, with the margin tied to the Issuer's credit rating going forward. Net proceeds from the notes are earmarked for general corporate purposes, including repaying borrowings under the new facility, or under the ABL facility if the refinancing is not completed. Final notes terms, including maturity, coupon, and principal amount, will depend on market conditions at pricing and were not disclosed in this filing.
Overall, the transaction is primarily a liability management and maturity-extension exercise. It addresses the 2025 notes maturity and the 2026 secured facility maturities, and it gives HCA more flexible unsecured funding. The filing does not disclose new earnings, cash flow, or operating results, and the terms of the offering remain subject to market conditions.
02—Key points
Key Highlights
- HCA Inc. proposed a senior unsecured notes offering; final maturity, coupon, and principal amount depend on market conditions at pricing.
- The Issuer repaid at maturity all $2.600 billion of its 5.375% Senior Notes due 2025, funded partly by $2.950 billion of ABL facility borrowings as of February 14, 2025.
- The existing Cash Flow ($3.5B revolver plus term loan A) and ABL ($4.5B revolver) secured facilities are to be terminated and repaid, having been set to mature June 30, 2026.
- A new $8.000 billion five-year senior unsecured revolving facility will replace the secured facilities, with sublimits of $400M for multicurrency borrowings, $750M for letters of credit, and $250M for swingline loans.
- The new facility is not guaranteed by HCA Healthcare or any subsidiary of the Issuer, reflecting a structural shift away from secured, guaranteed debt.
- Financial covenant: quarterly maximum leverage ratio of 4.50x, with an election to step up to 5.00x for specified periods after a material acquisition.
- Expected initial pricing of Term SOFR plus 1.250% plus a 0.10% credit spread adjustment, with the margin set by the Issuer's credit rating going forward.
03—Questions
Frequently Asked Questions
Why is HCA issuing senior notes now?
The offering supports general corporate purposes, including repaying borrowings under the existing ABL facility or the proposed new senior unsecured facility. The filing ties it to refinancing the 2025 notes maturity and the secured credit facilities that mature in June 2026.
Will the new credit facility be secured or guaranteed?
Neither. The $8.000 billion senior unsecured revolving facility will not be guaranteed by HCA Healthcare or any subsidiary of the Issuer, and it is not described as secured by collateral.
What financial covenant applies to the new facility?
The Issuer must keep its leverage ratio at or below 4.50x, tested quarterly. It may elect a step-up to 5.00x during specified periods following a material acquisition.
What will the new facility cost to borrow?
The Issuer expects initial borrowings to bear interest at Term SOFR plus 1.250%, plus a 0.10% credit spread adjustment. The margin will thereafter be based on the Issuer's credit rating.
What is still unknown about the offering?
The notes' maturity, interest rate, and principal amount were not set in this filing and will depend on market conditions at pricing. The filing also does not disclose the timing of closing or whether the refinancing will be completed as planned.
04—Continue